[ad_1]
A charity must start funding a clinical trial involving the use of cannabis oil to treat pain and itching in adults with a potentially life-threatening skin condition.
The trial will be launched by DEBRA, the only national charity serving people with epidermolysis bullosa (EB), a condition that causes blisters and tears in the skin at the slightest touch.
EB currently affects more than 5,000 people in the UK and causes pain and itching. The ampoules must be drained and treated daily.
Current treatments include prolonged use of opiates and anti-inflammatories, known to cause unwanted and unnecessary side effects.
According to DEBRA, the trial hopes to find out whether the use of cannabinoid-based drugs could improve the lives of people with EB, and involve the administration of an oil-like droplet under language.
Fifteen participants, aged 18 and over, will participate in the study over a period of three years at the Center for Blistering Diseases at the Groningen University Medical Center in the Netherlands.
Caroline Collins, Director of Research at DEBRA, said, "We are extremely pleased to fund this clinical trial, especially in light of the government's decision to legalize certain forms of cannabis for medical purposes.
"Anecdotal reports from people with EB suggest that cannabinoid-based medicines (TCMs) are effective at controlling the symptoms of pain and itching.
"The clinical trial will begin to gather the scientific evidence needed to prove that CRD is an effective treatment for pain and itching caused by Eb. We hope this will improve the quality of life of many people. "
Simon Weston, CBE, President of DEBRA, added, "For many years, I was taking opioids to relieve the pain of injury and surgery. Another method of pain control will be a welcome relief. "
[ad_2]
Source link
